Florian Kronenberg - Publications#


Number of publications (July 2022): Roughly 500 publications in total including 400 original articles and 100 reviews, editorials, book chapters and letters
H-index: 93 (Scopus), 108 (Google Scholar)
Number of citations: 37.156 (Scopus), 47.408 (Google Scholar)

Only a few selected publications as first, corresponding or senior author are listed:

1. Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoğlu LS, Catapano AL: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, (in press, 2022).

2. Di Maio S, Lamina C, Coassin S, Forer L, Würzner R, Schönherr S, Kronenberg F: Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events. J Intern Med 291:101-107, 2022.

3. Schachtl-Riess JF, Kheirkhah A, Grüneis R, Di Maio S, Schoenherr S, Streiter G, Losso JL, Paulweber B, Eckardt K-U, Köttgen A, Lamina C, Kronenberg F*, Coassin S*: Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease. Journal of the American College of Cardiology 78: 437-449, 2021.

4. Kronenberg F: Aortic valve stenosis: the long and winding road. Eur Heart J, 42:1212-1214, 2021.

5. Fazzini F, Lamina C, Raschenberger J, Schultheiss UT, Kotsis F, Schönherr S, Weissensteiner H, Forer L, Steinbrenner I, Meiselbach H, Bärthlein B, Wanner C, Eckardt K-U, Köttgen A, Kronenberg F: Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease. Kidney International 98: 488-497, 2020.

6. Lamina C, Kronenberg F: Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis. JAMA Cardiol. 4:575-579, 2019.

7. Fazzini F, Lamina C, Fendt L, Schultheiss UT, Kotsis F, Hicks AA, Meiselbach H, Weissensteiner H, Forer L, Krane V, Eckardt KU, Köttgen A, Kronenberg F: Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease. Kidney Int. 96:480-488, 2019.

8. Kronenberg F: HDL in CKD - the devil is in the detail. J. Am. Soc. Nephrol. 29:1356-1371, 2018, (Invited Review).

9. Coassin S, Erhart G, Weissensteiner H, Eca Guimaraes de AM, Lamina C, Schönherr S, Forer L, Haun M, Losso JL, Köttgen A, Schmidt K, Utermann G, Peters A, Gieger C, Strauch K, Finkenstedt A, Bale R, Zoller H, Paulweber B, Eckardt KU, Hüttenhofer A, Huber LA, Kronenberg F: A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction. Eur. Heart J. 38:1823-1831, 2017.

10. Matsushita K, Ballew SH, Coresh J, Arima H, Arnlov J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F: Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 5:718-728, 2017.

11. Kollerits B, Lamina C, Huth C, Marques-Vidal P, Kiechl S, Seppala I, Cooper J, Hunt SC, Meisinger C, Herder C, Kedenko L, Willeit J, Thorand B, Dähnhardt D, Stöckl D, Willeit K, Roden M, Rathmann W, Paulweber B, Peters A, Kähönen M, Lehtimäki T, Raitakari OT, Humphries SE, Vollenweider P, Dieplinger H, Kronenberg F: Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals. Diabetes Care 40:1386-1393, 2017.

Imprint Privacy policy « This page (revision-8) was last changed on Friday, 22. July 2022, 13:01 by Kronenberg Florian
  • operated by